Connect
MJA
MJA

Pharmacoepidemiology of testosterone prescribing in Australia, 1992–2010

Stephen P Fitzgerald
Med J Aust 2012; 197 (6): 329-330. || doi: 10.5694/mja12.11014
Published online: 17 September 2012

To the Editor: Could Handelsman comment on whether he considered opioid-associated hypoandrogenism when describing the increasing prescribing of testosterone?1 Opioid-induced androgen deficiency has become more recognised, and is one of the most common causes of testosterone deficiency among men in many communities.2,3 It may be that the increase in opioid prescribing4 has complemented the promotion of testosterone therapy.

  • Stephen P Fitzgerald

  • Royal Adelaide Hospital, Adelaide, SA.


Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.